Stock listing
SGP Stock Price, News, Filings & Events — Spyglass Pharma, Inc.
Selected listing: SGP · BOATS · USD · US
This page tracks Spyglass Pharma, Inc.'s SGP:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SGP:BOATS. SGP:BOATS is the stock-level entry point for investors researching Spyglass Pharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Spyglass Pharma, Inc. is a public company traded under the ticker SGP in the American market. With a market capitalization of approximately $685 million, Spyglass Pharma focuses on developing innovative pharmaceutical solutions. The company is committed to advancing healthcare through its research and development efforts.

- Ticker
- SGP:BOATS
- Asset type
- Stock
- Market cap
- $920.5M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
Spyglass Pharma, Inc. SGP:BOATS stock context
This page tracks Spyglass Pharma, Inc.'s SGP:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SGP:BOATS. SGP:BOATS is the stock-level entry point for investors researching Spyglass Pharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Spyglass Pharma, Inc. is a public company traded under the ticker SGP in the American market. With a market capitalization of approximately $685 million, Spyglass Pharma focuses on developing innovative pharmaceutical solutions. The company is committed to advancing healthcare through its research and development efforts.
Latest news from Spyglass Pharma, Inc.
SpyGlass Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
August 6, 2026
SpyGlass Pharma Appoints Shannon Treviño as General Counsel
June 15, 2026
SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing
June 2, 2026
SpyGlass Pharma to Participate in Upcoming Investor Conferences
May 21, 2026
SpyGlass Pharma Announces New Add-on Category III CPT Code for Its Innovative BIM-IOL System
May 18, 2026
Research Spyglass Pharma, Inc.
Spyglass Pharma, Inc. investor report
Review AI stock analysis and investor report context for SGP:BOATS.
Spyglass Pharma, Inc. company profile
View the public company page for Spyglass Pharma, Inc. on 6ix.
Spyglass Pharma, Inc. news
Read company news and market updates connected to Spyglass Pharma, Inc..
Spyglass Pharma, Inc. investor events
Find investor webinars, events, and replay context for Spyglass Pharma, Inc..